Hält derzeit Positionen bei Neurocrine Biosciences Inc, Fate Therapeutics Inc, Regulus Therapeutics Inc and Dare Bioscience Inc
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | Neurocrine Biosciences Inc | 1. Mai 2011 - |
Independent Chairman of the Board | Fate Therapeutics Inc | 1. November 2011 - |
Independent Director | Regulus Therapeutics Inc | 1. April 2013 - |
Lead Independent Director | Dare Bioscience Inc | None - |
Independent Chairman of the Board | Illumina Inc | 27. Januar 2005 - 28. Januar 2016 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-05-03 | 2023-05-01 |
Neurocrine Biosciences Inc
(NBIX)
|
GV Geplanter Verkauf |
4.300
-9.1%
101,43436.135 USD |
4.300 -9.1% | 101,43 | 436.135 USD | |
2023-04-21 | 2023-04-21 |
Neurocrine Biosciences Inc
(NBIX)
|
GV Geplanter Verkauf |
6.034
-13.3%
105,04633.787 USD |
6.034 -13.3% | 105,04 | 633.787 USD | |
2023-04-21 | 2023-04-19 |
Neurocrine Biosciences Inc
(NBIX)
|
GV Geplanter Verkauf |
903
-2.5%
105,0094.819 USD |
903 -2.5% | 105,00 | 94.819 USD | |
2022-04-05 | 2022-04-01 |
Neurocrine Biosciences Inc
(NBIX)
|
GV Geplanter Verkauf |
10.728
-24.0%
94,931.018.366 USD |
10.728 -24.0% | 94,93 | 1.018.366 USD | |
2019-05-08 | 2019-05-07 |
Regulus Therapeutics Inc
(RGLS)
|
K Kauf |
92.889
+151.4%
1,08100.320 USD |
92.889 +151.4% | 1,08 | 100.320 USD | |
2017-07-25 | 2017-07-25 |
Regulus Therapeutics Inc
(RGLS)
|
K Kauf |
274.725
+78.5%
0,91250.000 USD |
274.725 +78.5% | 0,91 | 250.000 USD | |
2017-03-07 | 2017-03-07 |
Regulus Therapeutics Inc
(RGLS)
|
K Kauf |
250.000
+250.0%
1,15287.500 USD |
250.000 +250.0% | 1,15 | 287.500 USD | |
2004-05-26 | 2004-05-24 |
Biogen Inc
(BIIB)
|
V Verkauf |
29.081
-26.9%
62,511.817.714 USD |
29.081 -26.9% | 62,51 | 1.817.714 USD | |
2004-05-20 | 2004-05-19 |
Biogen Inc
(BIIB)
|
V Verkauf |
25.000
-18.8%
60,031.500.750 USD |
25.000 -18.8% | 60,03 | 1.500.750 USD | |
2004-05-06 | 2004-05-04 |
Biogen Inc
(BIIB)
|
V Verkauf |
25.000
-13.5%
58,831.470.750 USD |
25.000 -13.5% | 58,83 | 1.470.750 USD | |
2004-05-06 | 2004-05-04 |
Biogen Inc
(BIIB)
|
V Verkauf |
80.000
-47.2%
58,684.694.400 USD |
80.000 -47.2% | 58,68 | 4.694.400 USD | |
2004-05-06 | 2004-05-04 |
Biogen Inc
(BIIB)
|
V Verkauf |
25.000
-12.8%
58,831.470.750 USD |
25.000 -12.8% | 58,83 | 1.470.750 USD |